MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 355 filers reported holding MEDIVATION INC in Q3 2015. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,841,000 | +36.0% | 47,192 | +0.8% | 0.25% | +28.1% |
| Q2 2016 | $2,824,000 | +37.1% | 46,837 | +4.6% | 0.19% | +28.9% |
| Q1 2016 | $2,060,000 | -15.7% | 44,793 | -11.4% | 0.15% | -19.5% |
| Q4 2015 | $2,445,000 | -59.9% | 50,578 | -31.8% | 0.18% | -70.2% |
| Q3 2015 | $6,096,000 | +222.2% | 74,180 | +347.7% | 0.62% | +220.1% |
| Q2 2015 | $1,892,000 | +24.6% | 16,568 | +40.8% | 0.19% | +16.2% |
| Q1 2015 | $1,518,000 | +156.0% | 11,764 | +97.5% | 0.17% | +116.9% |
| Q4 2014 | $593,000 | +161.2% | 5,957 | +159.5% | 0.08% | +92.5% |
| Q3 2014 | $227,000 | – | 2,296 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |